Discovering State-of-the-Art Novel Targets, Biomarkers & Delivery Technology to Propel New Approvals for the High Unmet Need in Hearing Disorders

The Definitive Industry Forum Dedicated to Accelerating New Otoprotective, Restorative & Regenerative Gene Therapies, Small Molecules & Cell Therapies

2024 has started off with a bang with recent back-to-back positive results for gene therapy for rare genetic hearing disorders and major headways in otoprotective, restorative and regenerative small molecules and cell therapies for acquired hearing loss.

At this prime time comes the return of the Inner Ear Disorders Therapeutics Summit for its 4th edition, presenting an unparalleled opportunity to unite with the community and discuss the next generation of inner ear R&D with novel drug modalities.

Don’t miss out on your premium opportunity to meet and network with this niche audience of 75+ industry-based discovery, biology, preclinical, translational and clinical scientists from the likes of Regeneron, Refreshgene Therapeutics, Spiral Therapeutics, Acousia Therapeutics, Ting Therapeutics, Massachusetts Eye and Ear Infirmary, Gateway Biotechnologies and more as they examine how to efficiently translate more therapeutic indications into the clinic.

World-Class Auditory & Otolaryngology Experts Include:

Event Guide Cover

Download the 2024 Event Guide for More Information On:

  • 18+ Expert Speaker Faculty 
  • Interactive Workshops
  • Full access to the 3-day agenda and scientific content breakdown 
  • and more!

Past Attendees Include:

2560px-Boehringer_Ingelheim_Logo.svg
Fennec Pharmaceuticals
myrtelle
johnson
Regeneron Pharmaceuticals
astellas
sensorion
rinri-logo-ret
Sound Pharmaceuticals
2560px-University_College_London_logo.svg
hms_logo_final_rgb_0
Decibel Therapeutics
Massachusetts-Eye-Ear-Infirmary
Spiral Therapeutics
neurocrine

Proud To Partner With:

49041 Partners

Other Events in the Sensory Series: